ReviewJournal of experimental & clinical cancer research : CR2021

The CD112R/CD112 axis: a breakthrough in cancer immunotherapy.

Taofei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.